Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul P S Wang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|May 7, 2016
BAM-matcher: a tool for rapid NGS sample matchingPaul P S Wang, Wendy T Parker, Susan Branford, et al.
Leukemia|February 21, 2020
Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemiaDaniel W Thomson, Nur Hezrin Shahrin, Paul P S Wang, et al.
Blood Advances|January 4, 2018
<i>ASXL1</i> and <i>BIM</i> germ line variants predict response and identify CML patients with the greatest risk of imatinib failureJustine E Marum, David T Yeung, Leanne Purins, et al.
Endocrine Pathology|September 2, 2019
The Genomic Landscape of Sporadic ProlactinomasSunita M C De Sousa, Paul P S Wang, Stephen Santoreneos, et al.
Neoplasia (New York, N.Y.)|November 26, 2021
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibitionMelissa K Bennett, Manjun Li, Melinda N Tea, et al.
Leukemia|April 14, 2021
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerDeepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Blood Advances|March 26, 2020
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AMLAnna L Brown, Peer Arts, Catherine L Carmichael, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|May 7, 2016
BAM-matcher: a tool for rapid NGS sample matchingPaul P S Wang, Wendy T Parker, Susan Branford, et al.
Leukemia|February 21, 2020
Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemiaDaniel W Thomson, Nur Hezrin Shahrin, Paul P S Wang, et al.
Blood Advances|January 4, 2018
<i>ASXL1</i> and <i>BIM</i> germ line variants predict response and identify CML patients with the greatest risk of imatinib failureJustine E Marum, David T Yeung, Leanne Purins, et al.
Endocrine Pathology|September 2, 2019
The Genomic Landscape of Sporadic ProlactinomasSunita M C De Sousa, Paul P S Wang, Stephen Santoreneos, et al.
Neoplasia (New York, N.Y.)|November 26, 2021
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibitionMelissa K Bennett, Manjun Li, Melinda N Tea, et al.
Leukemia|April 14, 2021
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerDeepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Blood Advances|March 26, 2020
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AMLAnna L Brown, Peer Arts, Catherine L Carmichael, et al.
Pageof 1